MOSAIC is a five-year global project to accelerate introduction and scale-up of new biomedical prevention products and expedite their availability, acceptance, uptake, and impact in PEPFAR programs to help individuals, especially women, prevent HIV and other infectious diseases.
Meaningful engagement of young people is a key strategy of the MOSAIC project and CATALYST, its flagship study of choice in HIV prevention. But what does meaningful youth engagement really mean? As a youth representative of MOSAIC’s NextGen Squad and a program coordinator supporting MOSAIC implementation in Namibia, I have had a chance to experience it first-hand.
Continue Reading
Three MTN studies – REACH, DELIVER, and B-PROTECTED – recently published critical new data on PrEP ring use among adolescent girls and young women (AGYW), pregnant individuals, and breastfeeding individuals in Africa. All studies offer compelling evidence that the ring is safe for use among these populations.
Continue Reading
Through oral PrEP, condoms, voluntary medical male circumcision, and antiretroviral treatment, USAID has helped to expand prevention options and access for all. Today, USAID continues to provide global leadership in the HIV response by expanding access to options with a new generation of HIV prevention products.
Continue Reading
The world is closer than ever to ending HIV as a public health threat. As the global response to the HIV epidemic continues to transition from an emergency response to one focused on sustaining the progress we’ve made, it is critical that we continue to find innovative solutions to address new challenges.
Continue Reading
Emerging products provide more options and the potential for individuals to find the HIV prevention methods that best suit their needs and preferences. But what does PrEP choice look like, and how can it be protected for all individuals who could benefit from HIV prevention? This blog post presents the choice principles, offers illustrative examples of each principle, and outlines what could come next to advance choice in HIV prevention efforts.
Continue Reading
Expanding access to and uptake of PrEP products among young people, especially adolescent girls and young women, will be key to ending the HIV epidemic. But how do we ensure HIV prevention efforts resonate with and are effective for young millennials and Gen Z? What does meaningful youth engagement in PrEP delivery really mean?
Continue Reading
What sets CATALYST apart is the study’s emphasis on meaningful involvement of young people at every stage of the research to understand end-user perspectives and help tailor the study to meet their needs. This makes us hopeful because the inclusion of young people in the CATALYST journey has not been tokenistic; rather our contributions have been reflected in the whole process so far. In this post, we describe three ways youth have been engaged in CATALYST.
Continue Reading
This IAS 2023 session will review evidence from recent studies designed to inform CAB PrEP introduction in Asia; identify regional priorities for a CAB implementation science agenda; examine regional lessons from oral PrEP introduction and scale-up; highlight progress and lessons from preparing for CAB rollout in Africa; and introduce available policy and program planning tools and resources to help countries prepare for CAB rollout.
Continue Reading
As marketing for PrEP has evolved, we have seen a shift away from strategies we know don’t work: fear-based, stigma-reinforcing, HIV-centric, medicalized, and far-future focused. Yet we need to go a step further and analyze all the insights that form the backbone of our campaigns and our messages through a gender-transformative lens.
Continue Reading
We are excited to announce the launch of Catalyzing Access to New Prevention Products to Stop HIV (CATALYST), MOSAIC’s flagship product introduction study. CATALYST will provide and assess an enhanced service delivery package that includes oral PrEP, the PrEP ring, and injectable cabotegravir for PrEP.
Continue Reading